[시장보고서]자기공명영상(MRI) 시장 규모, 점유율, 동향 분석 보고서 : 아키텍처별, 자장 강도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

자기공명영상(MRI) 시장 규모, 점유율, 동향 분석 보고서 : 아키텍처별, 자장 강도별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Magnetic Resonance Imaging Market Size, Share & Trends Analysis Report By Architecture (Open Systems, Closed Systems), By Field Strength (Low, Mid, High) By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1726183

리서치사 : Grand View Research

발행일 : 2025년 04월

페이지 정보 : 영문 210 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,596,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,041,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,930,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

자기공명영상(MRI) 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 자기공명영상(MRI) 시장 규모는 2025-2030년에 걸쳐 CAGR 6.5%를 나타내, 2030년까지 103억 달러에 달할 것으로 예측되고 있습니다.

만성 질환의 유병률 증가나 조기 진단 기술에 대한 수요 증가가 시장 성장을 가속하는 요인으로서 기대되고 있습니다.또, 침습성이 낮은 수기의 채용이 증가하고 있는 것도 시장 성장에 기여하고 있습니다. 성과 효율성을 이해하기 위한 임상검사 증가가 시장성장을 뒷받침할 것으로 기대되고 있습니다.

연구 조사 증가는 전임상과 임상의 폭넓은 용도에 있어서의 고자장 MRI 장치의 잠재적인 용도와 이점의 해명에 공헌하는 것으로 예측됩니다. 에어의 도입으로 스캐닝의 신속화와 영상 워크플로우의 합리화가 실현되었습니다. 소프트웨어 업데이트는 사용자에게 시스템을 강화하고 워크플로우 효율성을 향상시킬 수 있는 기회를 설명합니다.

자기공명영상(MRI) 시장 보고서 하이라이트

폐쇄계 시스템 부문이 2024년에 75.6%의 최대 수익 점유율로 시장을 독점했습니다.
MRI 장치는 자장 강도에 따라 분류되며 1.5T 이하의 저자장 강도 MRI 장치, 1.5T에서 3T까지의 중자장 MRI 장치, 3T를 초과하는 고자장 MRI 장치가 있습니다.
뇌·신경 부문은 알츠하이머병, 파킨슨병, 다발성 경화증등의 신경 질환의 유병률 상승에 기인해, 2024년에 최대의 수익 점유율을 차지했습니다.
병원 부문은 종합적인 의료 서비스 제공에 중요한 역할로 인해 2024년에 가장 큰 시장 점유율을 차지했습니다.
북미의 자기공명영상(MRI) 시장은 2024년에 36.4%의 최대 수익 점유율로 시장을 독점했습니다.

지역별 시장 대시보드
지역별 시장 점유율 분석(2024년, 2030년)
지역별 자기공명영상(MRI) 시장 : 주요 포인트
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제9장 경쟁 구도

주요 시장 진출기업에 의한 최근의 동향과 영향 분석
기업/경쟁의 분류
공급업체 상황
- 주요 기업의 히트맵 분석(2024년)
기업 프로파일
- GE HealthCare
- Siemens Healthineers AG
- Koninklijke Philips NV
- CANON MEDICAL SYSTEMS CORPORATION
- Hitachi Healthcare(Hitachi High-Tech Corporation)
- Hologic, Inc.
- Bruker
- Esaote SPA
- Fujifilm Holdings Corporation
- Shimadzu Corporation
- Aurora Imaging Technologies, Inc.(AURORA HEALTHCARE US CORP)

KTH

영문 목차

영문목차

Magnetic Resonance Imaging Market Growth & Trends:

The global magnetic resonance imaging market size is expected to reach USD 10.3 billion by 2030, registering a CAGR of 6.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of chronic diseases and increasing demand for early diagnostic techniques are the factors expected to drive the market growth. In addition, the growing adoption of less invasive procedures is contributing to the market growth. Moreover, the growing number of clinical trials to understand the effectiveness and efficiency of MRI machines in various clinical applications is expected to boost market growth. End-users, such as research institutes and universities, are actively conducting studies to assess the effectiveness of high-field strength MRI devices, including those with field strengths of 7T, 10T, and 10.5T.

The increasing number of research investigations will contribute to unveiling the potential uses and benefits of high-field MRI machines for a wide range of both preclinical and clinical applications. Technological advancements are further expected to boost the industry growth. The introduction of new software has resulted in quicker scanning and streamlined imaging workflows. Recent progress has facilitated the creation of multi-contrast and cardiac MRI, enhancing imaging capabilities. Software updates provide users with the opportunity to enhance their systems and improve workflow efficiency. As an illustration, in November 2021, Philips unveiled an AI-enabled MR imaging portfolio designed to enhance radiology operations' efficiency and sustainability. This portfolio accelerates MR exams, simplifies workflows, enhances diagnostic quality, and ensures the overall efficiency and sustainability of radiology operations.

Magnetic Resonance Imaging Market Report Highlights:

The closed systems segment dominated the market with the largest revenue share of 75.6% in 2024, driven by its superior ability to offer enhanced safety, reduced contamination risks, and more controlled environments for imaging procedures.
MRI machines are categorized based on their field strength, with low-field strength MRI machines having a field strength lower than 1.5T, mid-field MRI machines ranging from 1.5T up to 3T, and high-field MRI machines with a field strength exceeding 3T.
The brain & neurological segment accounted for the largest revenue share in 2024, owing to the rising prevalence of neurological disorders such as Alzheimer's, Parkinson's, and multiple sclerosis.
The hospitals segment held the largest market share in 2024, attributed to their critical role in providing comprehensive healthcare services.
North America magnetic resonance imaging market dominated the market with the largest revenue share of 36.4% in 2024.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Architecture
- 1.2.2. Field Strength
- 1.2.3. Application
- 1.2.4. End Use
- 1.2.5. Regional Scope
- 1.2.6. Estimates and Forecasts Timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
1.5. Information or Data Analysis
- 1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Architecture Outlook
- 2.2.2. Field Strength Outlook
- 2.2.3. Application Outlook
- 2.2.4. End Use Outlook
- 2.2.5. Regional Outlook
2.3. Competitive Insights

Chapter 3. Magnetic Resonance Imaging Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Magnetic Resonance Imaging Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat of New Entrant
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
  - 3.3.2.1. Political Landscape
  - 3.3.2.2. Technological Landscape
  - 3.3.2.3. Economic Landscape

Chapter 4. Magnetic Resonance Imaging Market: Architecture Estimates & Trend Analysis

4.1. Architecture Segment Dashboard
4.2. Magnetic Resonance Imaging Market: Architecture Movement Analysis
4.3. Global Magnetic Resonance Imaging Market Size & Trend Analysis, by Architecture, 2018 to 2030 (USD Million)
4.4. Open Systems
- 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5. Closed Systems
- 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Magnetic Resonance Imaging Market: Field Strength Estimates & Trend Analysis

5.1. Field Strength Segment Dashboard
5.2. Magnetic Resonance Imaging Market: Field Strength Movement Analysis
5.3. Global Magnetic Resonance Imaging Market Size & Trend Analysis, by Field Strength, 2018 to 2030 (USD Million)
5.4. Low
- 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5. Mid
- 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6. High
- 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Magnetic Resonance Imaging Market: Application Estimates & Trend Analysis

6.1. Application Segment Dashboard
6.2. Magnetic Resonance Imaging Market: Application Movement Analysis
6.3. Global Magnetic Resonance Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
6.4. Obstructive Sleep Apnea
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5. Brain & Neurological
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6. Spine & Musculoskeletal
- 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7. Vascular
- 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8. Abdominal
- 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.9. Cardiac
- 6.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.10. Breast
- 6.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.11. Others
- 6.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Magnetic Resonance Imaging Market: End Use Estimates & Trend Analysis

7.1. End Use Segment Dashboard
7.2. Magnetic Resonance Imaging Market: End Use Movement Analysis
7.3. Global Magnetic Resonance Imaging Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
7.4. Hospitals
- 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5. Imaging Centers
- 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6. Ambulatory Surgical Centers
- 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7. Others
- 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Magnetic Resonance Imaging Market: Regional Estimates & Trend Analysis

8.1. Regional Market Dashboard
8.2. Regional Market Share Analysis, 2024 & 2030
8.3. Magnetic Resonance Imaging Market by Region: Key Takeaways
8.4. North America
- 8.4.1. U.S.
  - 8.4.1.1. Key Country Dynamics
  - 8.4.1.2. Regulatory Framework/ Reimbursement Structure
  - 8.4.1.3. Competitive Scenario
  - 8.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.4.2. Canada
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Regulatory Framework/ Reimbursement Structure
  - 8.4.2.3. Competitive Scenario
  - 8.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.4.3. Mexico
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Regulatory Framework/ Reimbursement Structure
  - 8.4.3.3. Competitive Scenario
  - 8.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.5. Europe
- 8.5.1. U.K.
  - 8.5.1.1. Key Country Dynamics
  - 8.5.1.2. Regulatory Framework/ Reimbursement Structure
  - 8.5.1.3. Competitive Scenario
  - 8.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.2. Germany
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Regulatory Framework/ Reimbursement Structure
  - 8.5.2.3. Competitive Scenario
  - 8.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.3. France
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Regulatory Framework/ Reimbursement Structure
  - 8.5.3.3. Competitive Scenario
  - 8.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.4. Italy
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Regulatory Framework/ Reimbursement Structure
  - 8.5.4.3. Competitive Scenario
  - 8.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.5. Spain
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Regulatory Framework/ Reimbursement Structure
  - 8.5.5.3. Competitive Scenario
  - 8.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.6. Denmark
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Regulatory Framework/ Reimbursement Structure
  - 8.5.6.3. Competitive Scenario
  - 8.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.7. Sweden
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Regulatory Framework/ Reimbursement Structure
  - 8.5.7.3. Competitive Scenario
  - 8.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.5.8. Norway
  - 8.5.8.1. Key Country Dynamics
  - 8.5.8.2. Regulatory Framework/ Reimbursement Structure
  - 8.5.8.3. Competitive Scenario
  - 8.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Japan
  - 8.6.1.1. Key Country Dynamics
  - 8.6.1.2. Regulatory Framework/ Reimbursement Structure
  - 8.6.1.3. Competitive Scenario
  - 8.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.2. China
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Regulatory Framework/ Reimbursement Structure
  - 8.6.2.3. Competitive Scenario
  - 8.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.3. India
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Regulatory Framework/ Reimbursement Structure
  - 8.6.3.3. Competitive Scenario
  - 8.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.4. Australia
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Regulatory Framework/ Reimbursement Structure
  - 8.6.4.3. Competitive Scenario
  - 8.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.5. Thailand
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Regulatory Framework/ Reimbursement Structure
  - 8.6.5.3. Competitive Scenario
  - 8.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.6.6. South Korea
  - 8.6.6.1. Key Country Dynamics
  - 8.6.6.2. Regulatory Framework/ Reimbursement Structure
  - 8.6.6.3. Competitive Scenario
  - 8.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Regulatory Framework/ Reimbursement Structure
  - 8.7.2.3. Competitive Scenario
  - 8.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Regulatory Framework/ Reimbursement Structure
  - 8.7.3.3. Competitive Scenario
  - 8.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.8. Middle East and Africa
- 8.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key Country Dynamics
  - 8.8.2.2. Regulatory Framework/ Reimbursement Structure
  - 8.8.2.3. Competitive Scenario
  - 8.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key Country Dynamics
  - 8.8.3.2. Regulatory Framework/ Reimbursement Structure
  - 8.8.3.3. Competitive Scenario
  - 8.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key Country Dynamics
  - 8.8.4.2. Regulatory Framework/ Reimbursement Structure
  - 8.8.4.3. Competitive Scenario
  - 8.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key Country Dynamics
  - 8.8.5.2. Regulatory Framework/ Reimbursement Structure
  - 8.8.5.3. Competitive Scenario
  - 8.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/ Competition Categorization
9.3. Vendor Landscape
- 9.3.1. Key company heat map analysis, 2024
9.4. Company Profiles
- 9.4.1. GE HealthCare
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Strategic Initiatives
- 9.4.2. Siemens Healthineers AG
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Strategic Initiatives
- 9.4.3. Koninklijke Philips N.V.
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Strategic Initiatives
- 9.4.4. CANON MEDICAL SYSTEMS CORPORATION
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Strategic Initiatives
- 9.4.5. Hitachi Healthcare (Hitachi High-Tech Corporation)
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Strategic Initiatives
- 9.4.6. Hologic, Inc.
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Strategic Initiatives
- 9.4.7. Bruker
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Strategic Initiatives
- 9.4.8. Esaote SPA
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Strategic Initiatives
- 9.4.9. Fujifilm Holdings Corporation
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Strategic Initiatives
- 9.4.10. Shimadzu Corporation
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Strategic Initiatives
- 9.4.11. Aurora Imaging Technologies, Inc. (AURORA HEALTHCARE US CORP)
  - 9.4.11.1. Company Overview
  - 9.4.11.2. Financial Performance
  - 9.4.11.3. Product Benchmarking
  - 9.4.11.4. Strategic Initiatives

한글목차

자기공명영상(MRI) 시장 성장과 동향

자기공명영상(MRI) 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 자기공명영상(MRI) 시장 변수, 동향, 범위

제4장 자기공명영상(MRI) 시장 : 아키텍처별, 추정 및 동향 분석

제5장 자기공명영상(MRI) 시장 : 자장 강도별, 추정 및 동향 분석

제6장 자기공명영상(MRI) 시장 : 용도별, 추정 및 동향 분석

제7장 자기공명영상(MRI) 시장 : 최종 용도별, 추정 및 동향 분석

제8장 자기공명영상(MRI) 시장 : 지역별, 추정 및 동향 분석